New research in the Canadian Medical Association Journal links emergency department opioid prescriptions to small increases in future opioid use and hospitalisations, but not death or overdose. The study highlights the need for cautious prescribing, especially in high-risk patients.
A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient. Researchers identified a RUFY1-RET fusion, highlighting the need for advanced genetic testing to guide treatment strategies and combat evolving resistance.
Sarah Kabbani and Michael Craig from the U.S. Centers for Disease Control and Prevention discuss the organization’s efforts to implement and support antibiotic stewardship.
How can the EU’s pharmaceutical legislation help tackle current challenges, including medicine shortages and antimicrobial resistance, across Europe? We put the question to Rainer Becker, Director for Medical Products and Innovation at DG SANTE.
Aiming to tackle the high risk of heart problems among older Americans with obesity, Medicare is contemplating an expansion of coverage for a weight-loss medication known as semaglutide.
Lorna Rothery spoke to Health Care Without Harm (HCWH) Europe about the impact of pharmaceutical pollution and the barriers that need to be overcome to achieve a greener, more sustainable industry.
Imagine a world where children's medicine tastes like chocolate, seniors can take just one pill for all their daily medications, and you can get a drug made specifically for your unique health needs right at your local pharmacy.
Ewan Townsend, Co-chair of Arnold & Porter’s Sustainability Committee, discusses the pharmaceutical sector’s shift towards environmentally friendly green chemistry.
Analysis of over 430,000 adults in the United States has unveiled concerning connections between cannabis consumption and heightened risks of heart attack and stroke.
A staggering 51.6 million Americans live with pain daily; Ellen Smith from the U.S. Pain Foundation tells us about how medical cannabis supports her management of chronic pain.
Leading independent European antisense drug discovery company, Secarna, aims to bring novel and effective antisense therapeutic options to an increasing number of patients. CEO Alexander Gebauer tells us how.
Alberto Sainz Cort to discuss the prevalence of chronic pain and opioid use in the United States, as well as medical cannabis as a potential treatment for pain.
